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Abstract The purpose of this study is to investigate the
relationship between acne and insulin resistance as well as
other metabolic impairment in young males. Acne is a skin
disease that can be influenced by endocrine abnormalities.
In females, it is associated with polycystic ovary syndrome,
with peripheral insulin resistance and hyperinsulinemia,
whereas few data are available in males. For investigating
this, 22 young males with acne have been compared to 22
controls of comparable age and gender. Acne was scored
using the global acne grading system score. Clinical as well
as biochemical parameters of glucose and lipid metabo-
lism, circulating levels of androgens, and IGF-1 were
evaluated. Oral glucose tolerance test was performed and
homeostasis model assessment of insulin resistance was
calculated. The results thus obtained are as follows,
patients had higher BMI (p = 0.003), WC (p = 0.002),
WHR (p = 0.02), SBP (p = 0.0001), DBP (p = 0.001),
basal (p = 0.01) and 120 min. oGTT serum insulin con-
centrations (p = 0.002), basal glucose concentrations
(p = 0.03), HOMA-IR (p = 0.016), and lower HDL-cho-
lesterol than controls (p = 0.001). Among the subgroup of
subjects with BMI\24.9, HDL-cholesterol (p = 0.05) and
120 min. oGTT serum insulin concentrations (p = 0.009)
resulted to be independent predictors of acne at multivar-
iate analysis. In conclusion, these findings highlight a
metabolic imbalance in young males affected with acne.
Insulin resistance seems to play the main role for the
development of acne in these subjects. Insulin resistance
could represent an effective target for therapy in male acne.
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Introduction
Acne is a common and complex skin disease. It is a chronic
inflammation of pilosebaceous unit, which involves
hyperkeratosis and sebaceous hypersecretion. It is more
prevalent in adolescence and in female gender and is
commonly located in face, shoulders, back, and chest.
Genetic modeling using acne scores showed that 81 % of
the variance of the disease was attributable to additive
genetic effects [1].
Sebum production is one of the key factors in the
pathogenesis of acne [2]. Sebum production is regulated by
androgens, and in few cases androgen excess may influence
or aggravate acne in susceptible individuals [3, 4]. Sebum
production begins during puberty in correspondence with
the peaking levels of growth hormone and insulin-like
growth factor 1 (IGF-1) that occur in mid-puberty [5–9].
Acne can be related to some endocrine diseases: the
most common in females is polycystic ovary syndrome
(PCOS). There are acne symptoms in 70 % of PCOS cases.
PCOS is typically characterized by hyperandrogenism,
chronic anovulation, and polycystic ovaries. Women with
PCOS have abnormalities in the metabolism of androgens
and estrogen, and in the control of androgen production.
PCOS is also associated with peripheral insulin resistance
and hyperinsulinemia, and obesity amplifies the degree of
both abnormalities [10–12]. These rates show that there is a
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relationship between the metabolic profile and acne.
However, this relationship has not been investigated in
male gender.
In males, the relationship between acne and insulin
resistance has been poorly investigated. Smith et al. [13]
showed that a low-glycemic-load diet induced an
improvement in acne severity and in parallel in insulin-
sensitivity, as expressed by HOMA index, suggesting that
nutrition-related lifestyle factors may play a role in the
pathogenesis of acne.
The objective of this study was to investigate the relation-
ship between acne and insulin resistance as well as other
metabolic abnormalities in a sample of young males with acne.
Subjects and methods
Subjects
Twenty-two males with inflammatory acne were recruited
in the Department of Dermatology of Federico II Univer-
sity of Naples. This study included only male subjects aged
15–26 years who were affected with acne resistant to
common therapies. We classified as ‘‘resistant’’ those
patients affected with acne from a minimum of 1 year, with
no improvement during the last 6 months, also if they
performed all the strategies suggested by guidelines for
acne therapy [14]. We also evaluated 22 healthy subjects
without acne who were comparable for age and gender to
subjects with acne. There was a family history for type 2
diabetes mellitus in 7 subjects with acne (32 %) and 4
controls (18 %), without significant differences between
groups. The study was conducted after obtaining approval
from the Guarantee Committee Department for the case–
control Studies. A written informed consent was obtained
from each participant or guardian (if aged \18 years old).
Methods
At the dermatological examination, acne was classified
according to the degree of disease in mild-moderate-severe
acne by a global acne grading system (GAGS) [15. The
GAGS considers six locations on the face and chest/upper
back, with a factor for each location based toughly on
surface area, distribution, and density of pilosebaceous
units. The global score is the summation of all local scores
(0 = None, 1–18 = Mild, 19–30 = Moderate, 31–38 =
Severe, [39 = Very severe) [15].
Height, weight, body mass index (BMI), waist circum-
ference (WC), waist to hip ratio (WHR), and measurements
of systolic (SBP) and diastolic blood pressure (DBP) were
evaluated by standard methods. BMI was measured as the
ratio between the weight and the square of the height. A BMI
between 25 and 30 was considered as index of overweight
while[30 as index of obesity [16]. WC was measured as the
smallest torso circumference between the twelfth rib and the
iliac crest. WHR was measured as the ratio between the WC
and the circumference of the hip, considered as the maximal
extension of the buttocks. The measurements were per-
formed with the patients in standing position with relaxed
abdomen, arms at sides, and joined feet. WHR [0.8 in
females and WHR[0.95 in males are considered abnormal
values [17]. Blood pressure was measured in the right arm,
with the subjects in relaxed sitting position. The average of
six measurements (three taken by each of two examiners)
with a mercury sphygmomanometer was used. Hypertension
was diagnosed when DBP values were[90 mmHg and SBP
values were[140 mmHg. Hypertension was graded as grade
1 when DBP is between 90 and 99 mmHg and SBP between
140 and 159 mmHg, grade 2 when DBP is between 100 and
109 mmHg and SBP between 160 and 179 mmHg and grade
3 when DBP is[110 mmHg and SBP[180 mmHg [18].
To make the diagnosis of Metabolic Syndrome at least two
of the following criteria are required: the presence of abdom-
inal obesity which is defined with different cut-offs of the WC
according to ethnic group of the patients (for Europeans
[94 cm in men and[80 cm in females); serum triglycerides
[150 mg/dl, cholesterol levels HDL \40 mg/dl (in men) and
\50 mg/dl (in female) or lipid-lowering therapy, blood pres-
sure[130/85 mmHg or antihypertensive treatment, and fast-
ing glucose [100 mg/dl or previous diagnosis of diabetes
mellitus Type 2 [19–22].
In all subjects, serum blood samples were obtained by
standard methods to measure total (total-cholesterol;
\200 mg/dl) and high density lipoprotein cholesterol
(HDL-cholesterol;[45 mg/dl), triglycerides (\180 mg/dl),
glycemia (60–110 mg/dl), insulin (5–20 lU/ml), and gly-
cated hemoglobin (\6 %). An oral glucose tolerance test
(oGTT) was also performed (75 g of glucose diluted in
250 ml of saline solution, measuring blood glucose every
30 min for 2 h). The homeostasis model assessment of
insulin resistance (HOMA-IR; 0.23–2.5) was calculated as
fasting glucose 9 fasting insulin/405 [23].
The hormonal work-up included free testosterone
(15–40 lg/ml), total testosterone (10.4–34.7 nmol/l),
dehydroepiandrosterone sulfate (DHEAS; 35–430 lg/dl),
sex hormone-binding globulin (SHBG; 6–50 nmol/l), and
Insulin-like Growth Factor 1 (IGF-1; 90–280 mg/ml),
which were evaluated by standard methods using com-
mercially available kits.
Statistical analysis
Statistical analyses were performed by using SPSS 17.0 for
WINDOWS (SPSS Inc, Chicago, IL). The comparison
556 Endocrine (2012) 42:555–560
123
between numerical data was performed by the Wilcoxon
test. The correlation study was performed by the linear
regression analysis calculating the Pearson’s coefficient.
The multiple regression analysis was performed among the
variables correlated at the linear correlation. A ROC
analysis (receiver operator characteristic) was performed
by a non-parametric model to test that/those parameter/s
significantly distinguishing subjects with acne and controls
to determine the best cutoff in differentiating the two
groups. Data were reported as Mean ± SEM. p values
\0.05 were considered significant.
Results
Of the 22 subjects with acne, 7 had mild, 12 moderate, and 3
severe acne. Among these subjects, the biochemical work-up
identified a condition of impaired glucose tolerance in 4.5 %,
diabetes mellitus in none, while hypercholesterolemia was in
22 %. Grade 1 arterial hypertension was in 18 % of subjects
with acne, while grade 2 and grade 3 in none. Overweight
was in 36 %, obesity in 4.5 %, increased WC in 18 %, and
WHR in 10 %. Metabolic syndrome was in 36 % of subjects
with acne and in none of controls. At the linear correlation
study, there was a significant correlation between family
history for type 2 diabetes mellitus and BMI (r = 0.7,
p = 0.0001), WC (r = 0.5; p = 0.01), and WHR (r = 0.5,
p = 0.016) and an inverse correlation between acne score
and age of the subjects (r = -0.49, p = 0.02). As compared
to controls, the subjects with acne had higher BMI
(p = 0.003), WC (p = 0.002), WHR (p = 0.02), SBP
(p = 0.0001), DBP (p = 0.001), HOMA-IR (p = 0.016),
and lower HDL-cholesterol (p = 0.001). Total cholesterol,
triglycerides, serum IGF-1, and androgen levels were similar
in subjects with acne and controls (Table 1). Baseline serum
insulin and glucose concentrations were significantly higher
in subjects with acne (p \ 0.05). In parallel, oGTT curves
were significantly different between subjects with acne and
controls (Figs. 1, 2). At 120 min. oGTT, serum glucose
levels were similar between subjects with acne and controls,
while serum insulin levels were significantly higher in sub-
jects with acne than in controls (p = 0.002) (Table 1).
A subgroup analysis was then performed by excluding
subjects with overweight/obesity (BMI [24.9). At the
linear correlation study, among the 13 subjects with acne
and BMI B24.9, there was a significant correlation between
acne score and HOMA-IR (r = 0.50, p = 0.04), 120 min.
oGTT serum glucose levels (r = 0.56, p = 0.05), serum
IGF-1 levels (r = 0.60, p = 0.03), a correlation between
family history for type 2 diabetes mellitus and BMI
(r = 0.5, p = 0.04), and an inverse correlation persisted
between acne score and age (r = -0.70, p = 0.008).
By comparing the 13 subjects with acne and BMI B24.9
with 13 age-matched controls, SBP (p = 0.0001), DBP
Table 1 Clinical and metabolic
characteristics of subjects with
and without acne: whole
population
BMI body index mass, WHR
waist/hip ratio, HOMA-IR
homeostasis model assessment
of insulin resistance, SBP
systolic blood pressure, DBP
diastolic blood pressure,
DHEAS
dehydroepiandrosterone sulfate,
SHBG sex hormone-binding
globulin, WC waist
circumference, and oGTT oral
glucose tolerance test
Subjects with acne
(n = 22)
Subjects without acne
(n = 22)
p (Wilcoxon
test)
Age 18.6 ± 2.5 20.2 ± 3 0.06
BMI (Kg/m2) 24 ± 2.8 20.1 ± 1.5 0.003
WC (cm) 86.8 ± 9.8 83.4 ± 8 0.002
WHR 0.8 ± 0.1 0.7 ± 0.1 0.02
SBP (mmHg) 128.1 ± 7.9 112.5 ± 9 0.0001
DBP (mmHg) 80.9 ± 6.4 72.9 ± 7.8 0.001
Fasting serum glucose (mg/dl) 88.9 ± 7.8 84.3 ± 5.9 0.03
Fasting serum insulin (lU/mL) 10.6 ± 8.4 5.5 ± 1.4 0.01
120 min oGTT serum glucose
(mg/dl)
86.5 ± 19.4 85.4 ± 8.3 0.8
120 min oGTT serum insulin
(lU/mL)
30.1 ± 30.4 7.6 ± 1.2 0.002
HOMA-IR 1.7 ± 0.8 1.1 ± 0.3 0.016
Total cholesterol (mg/dl) 168.9 ± 33.1 166.7 ± 17.6 0.78
HDL cholesterol (mg/dl) 46.5 ± 8 57.3 ± 8 0.001
Triglycerides (mg/dl) 83 ± 3.2 78.5 ± 22.3 0.4
Serum IGF1(nmol/L) 338.8 ± 81 308 ± 58 0.15
Free testosterone (pg/ml) 16.8 ± 11.6 20 ± 14 0.82
Total testosterone (ng/dl) 5.1 ± 1.5 5.3 ± 1.3 0.92
DHEAS (lg/dl) 232.5 ± 142.7 211.7 ± 163.5 0.7
SHBG (nmol/L) 30.1 ± 8.1 31.6 ± 9.4 0.3
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(p = 0.03) and 120 min. oGTT serum insulin levels
(p = 0.009) were significantly higher in subjects with acne
than controls, while HDL-cholesterol was higher in con-
trols than in subjects with acne (p = 0.05) (Table 2). At
the multivariate analysis, there were two independent
predictors of acne: HDL-cholesterol (t = -2.6, p = 0.02)
and 120 min. oGTT serum insulin levels (t = 2.1,
p = 0.04). At the ROC analysis, a cut-off of HDL-cho-
lesterol of 48.5 mg/dl significantly distinguished subjects
with and without acne with sensitivity 61 % and specificity
92 % (p \ 0.003), while a cut-off of 120 min. oGTT serum
insulin levels of 9.6 lU/ml significantly distinguished
subjects with and without acne with sensitivity 85 % and
specificity 100 % (p \ 0.002).
Discussion
This study investigated the relationship between metabolic
abnormalities and acne in a sample of males affected with
acne. In females with acne and PCOS, insulin resistance is
a well known etiopathogenetic factor, while poor data are
available in males. Acne incidence has been related to
changes in insulin and IGF-1 circulating levels rather than
to changes in androgen levels. During puberty and ado-
lescence, there is a reduction in insulin sensitivity, com-
bined with an increase in IGF-1 and insulin serum levels
and a decrease in SHBG and IGFBP-1 serum levels. In
particular, insulin and IGF-1 levels peak during late pub-
erty and gradually decline until the third decade. Acne
begins about the same time as the preadolescent increase in
plasma insulin, IGF-1, and BMI, and generally resolves by
the end of puberty despite circulating androgens remain
unchanged [24]. Smith et al. [13, 24, 25] suggest that
increases in dietary glycemic load may augment the bio-
logical activity of IGF-1 as well as of sex hormones, sug-
gesting that dietary regimens rich in carbohydrates may
stimulate factors potentially involved in acne development.
In the current study, two groups of male subjects with
resistant acne and paired controls were considered
regardless from the type of dietary regimen. All subjects
with acne had a significant increase in BMI, WC, WHR,
SBP, DBP, HOMA-IR and 120 min. oGTT, and serum
insulin levels, and a significant reduction of HDL-choles-
terol values. The subgroup of young males with acne
showed in the majority of cases an impaired metabolic
profile and decreased insulin sensitivity, resulting in a
condition of metabolic syndrome in 36 % of them, while a
family history for type 2 diabetes mellitus also occurred in
32 % of them, indicating an imbalance in glucose/insulin
metabolism in this population.
One hypothesis is that metabolic impairment in these
subjects can influence one of the key pathogenesis factor of
acne, such as the proliferation of basal keratinocytes in the
sebaceous-pilosebaceous unit. These modifications can
aggravate the abnormal desquamation of follicular cor-
neocytes that is often altered in patients with acne. These
data suggest that insulin resistance might play an important
role in the development of acne in males that are no
responders to common therapies. With respect to females
with PCOS, who have hyperinsulinemia and hyperan-
drogenism [26, 27], in all males with acne here evaluated,
the androgenic profile was found to be normal, suggesting
that acne in these patients can be influenced by hyperin-
sulinemia but not by androgen activity. This finding is
supported by the fact that even in subjects with acne and
BMI \24.9 there is an independent relationship between
acne and hyperinsulinemia.
Beyond insulin, HDL cholesterol seems to be another
metabolic parameter influencing the development of acne
in males. In the current study, HDL-cholesterol resulted to
be an independent predictor of acne at the multivariate
analysis. A relationship between low HDL cholesterol
values and insulin resistance has been reported in females
Fig. 1 Comparison of mean concentrations of serum glucose for each
time of OGTT in subjects with acne and subjects without acne
Fig. 2 Comparison of mean concentrations of serum insulin for each
time of OGTT in subjects with acne and subjects without acne
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with acne [28, 29]. In male with acne, insulin resistance
seems to play a major role in the development of this skin
abnormality, while low HDL cholesterol likely influences
indirectly acne development through the metabolic syn-
drome, of which represents a well known risk factor.
Both these abnormalities might influence each other and
results in the induction of acne. On the other hand, increased
BMI as well as all other characteristics of metabolic syn-
drome affecting males with acne would be likely a conse-
quence of insulin resistance and low HDLcholesterol.
Finally, a cut-off of HDL-cholesterol of 48.5 mg/dl and
of 120 min. oGTT serum insulin levels of 9.6 lU/ml sig-
nificantly predict the presence of acne and should be used
to adopt a life-style intervention based on proper diet and
appropriate physical activity to improve lipid profile and
decrease insulin resistance.
Our study highlights a close relationship between
inflammatory acne and insulin resistance in males. In fact,
these findings show a worse metabolic profile in male
subjects affected with acne than in controls, consistent with
an increase in insulin resistance and decrease of HDL
cholesterol serum levels. These factors, as already seen in
female gender, are suggested such as a risk factor for
resistant acne in males. These preliminary data can suggest
that young males with acne can be investigated for insulin
sensitivity and lipid profile, to start the best dietary and/or
pharmacological treatment options.
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